Perfil
George W.
Masters is currently the Chairman at BioCatalyst Yorkton, Inc. He also holds director positions at Apollo BioPharmaceutics, Inc., ProScript, Inc., and Pharmx, Inc. Previously, he served as a director at Intelligent Medical Imaging, Inc. from 1994 to 1999 and at CompuCyte Corp.
Cargos activos de George W. Masters
Empresas | Cargo | Inicio |
---|---|---|
BioCatalyst Yorkton, Inc. | Presidente | 04/03/2010 |
Pharmx, Inc. | Director/Miembro de la Junta | 04/03/2010 |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Director/Miembro de la Junta | 04/03/2010 |
Apollo BioPharmaceutics, Inc.
Apollo BioPharmaceutics, Inc. BiotechnologyHealth Technology Part of Global Gaming Technologies Corp., Apollo BioPharmaceutics, Inc. is a company that researches and develops neuroprotective agents. The company is based in Cambridge, MA. Apollo BioPharmaceutics was acquired by MitoKor, Inc. on June 27, 2001 for $15 million. | Director/Miembro de la Junta | 04/03/2010 |
Antiguos cargos conocidos de George W. Masters.
Empresas | Cargo | Fin |
---|---|---|
Intelligent Medical Imaging, Inc.
Intelligent Medical Imaging, Inc. Medical SpecialtiesHealth Technology Intelligent Medical Imaging, Inc. has developed and is marketing the MICRO21 system, an intelligent, automated microscope system, for diagnostic use in hospital, commercial reference and physician group-practice laboratories. The MICRO21 system is designed to automate a broad range of manual microscopic procedures, potentially enabling the clinical laboratory to reduce costs and exposure to liabilities, enhance analytical accuracy and consistency, increase the productivity of medical technologists and improve patient care. The company is incorporated on June 1989 and is headquartered in Florida. | Director/Miembro de la Junta | 27/04/1999 |
CompuCyte Corp.
CompuCyte Corp. Medical SpecialtiesHealth Technology CompuCyte Corp. develops laser scanning products. Its comprehensive line of laser scanning cytometry instrumentation is applied to automated cellular and tissue analysis in life science research, drug safety, toxicology studies and clinical trials. The company was founded by Louis A. Kamentsky in 1992 and is headquartered in Westwood, MA. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 6 |
---|---|
BioCatalyst Yorkton, Inc. | |
Pharmx, Inc. | |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
CompuCyte Corp.
CompuCyte Corp. Medical SpecialtiesHealth Technology CompuCyte Corp. develops laser scanning products. Its comprehensive line of laser scanning cytometry instrumentation is applied to automated cellular and tissue analysis in life science research, drug safety, toxicology studies and clinical trials. The company was founded by Louis A. Kamentsky in 1992 and is headquartered in Westwood, MA. | Health Technology |
Apollo BioPharmaceutics, Inc.
Apollo BioPharmaceutics, Inc. BiotechnologyHealth Technology Part of Global Gaming Technologies Corp., Apollo BioPharmaceutics, Inc. is a company that researches and develops neuroprotective agents. The company is based in Cambridge, MA. Apollo BioPharmaceutics was acquired by MitoKor, Inc. on June 27, 2001 for $15 million. | Health Technology |
Intelligent Medical Imaging, Inc.
Intelligent Medical Imaging, Inc. Medical SpecialtiesHealth Technology Intelligent Medical Imaging, Inc. has developed and is marketing the MICRO21 system, an intelligent, automated microscope system, for diagnostic use in hospital, commercial reference and physician group-practice laboratories. The MICRO21 system is designed to automate a broad range of manual microscopic procedures, potentially enabling the clinical laboratory to reduce costs and exposure to liabilities, enhance analytical accuracy and consistency, increase the productivity of medical technologists and improve patient care. The company is incorporated on June 1989 and is headquartered in Florida. | Health Technology |
- Bolsa de valores
- Insiders
- George W. Masters